These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 600197)

  • 21. [Comparison of the antibacterial effects of gentamycin, tobramycin, dibekacin and amikacin in urinary germs].
    Rothenberger K; Friesen A; Streifinger W; Hofstetter A
    Fortschr Med; 1981 Oct; 99(40):1669-72. PubMed ID: 7298004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
    Husson MO; Izard D; Leclerc H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
    Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired cross resistance to aminoglycosides in gentamicin-sensitive and gentamicin-resistant strains of enterobacteria.
    Al-Asadi MJ; Towner K; Greenwood D
    J Med Microbiol; 1981 May; 14(2):171-83. PubMed ID: 7014903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro studies with netilmicin, amikacin, gentamicin, sissomicin and tobramycin.
    Habwe V; Shadomy S
    J Antimicrob Chemother; 1979 Jan; 5(1):73-9. PubMed ID: 762007
    [No Abstract]   [Full Text] [Related]  

  • 26. Patterns and mechanisms of antibiotic resistance.
    Murray BE; Moellering RC
    Med Clin North Am; 1978 Sep; 62(5):899-923. PubMed ID: 366296
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of neomycin, kanamycin, tobramycin and amikacin resistance mechanisms in gentamicin-resistant isolates of Enterobacteriaceae.
    Adwan K; Abu-Hasan N; Al-Asmar H
    J Med Microbiol; 1998 Nov; 47(11):1019-21. PubMed ID: 9822302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advances in antibiotics.
    McAllister TA
    Scott Med J; 1976 Oct; 21(4):210-7. PubMed ID: 793006
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative in vitro activity of netilmicin, amikacin, tobramycin and sisomicin against gentamicin highly-resistant enterobacteriaceae.
    Tselentis J; Legakis NJ; Nicolas KJ; Melissinos K; Papavassiliou J
    Chemotherapy; 1980; 26(6):409-17. PubMed ID: 7408554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotics and ERCP: in vitro activity of aminoglycosides when added to iodinated contrast agents.
    Jendrzejewski JW; McAnally T; Jones SR; Katon RM
    Gastroenterology; 1980 Apr; 78(4):745-8. PubMed ID: 7353761
    [No Abstract]   [Full Text] [Related]  

  • 33. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
    Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
    Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
    [No Abstract]   [Full Text] [Related]  

  • 34. New epidemiological data on resistance to netilmicin and other aminoglycosides.
    Toscano MA; Minneci M; Salmeri M; Nicoletti G
    J Chemother; 1991 Dec; 3(6):352-6. PubMed ID: 1819617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative evaluation of the activity "in vitro" of 4 aminoglycosides (gentamycin, sisomicin, tobramycin, amikacin)].
    Pinto L; Nobili B; Marchi K; Di Lena C; Esposito L
    Pediatria (Napoli); 1979 Sep; 87(3):399-406. PubMed ID: 550114
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology of resistance to netilmicin and other aminoglycosides.
    Toscano MA; Russo G; Nicoletti G; Stefani S; Geraci C; Alessandria E
    Chemioterapia; 1986 Jun; 5(3):191-5. PubMed ID: 3719853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
    Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
    Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.
    Acar JF; Witchitz JL; Goldstein F; Talbot JN; Le Goffic F
    J Infect Dis; 1976 Nov; 134 SUPPL():S280-5. PubMed ID: 825587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.